ADC Therapeutics SA 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001771910-25-000008
- Form type
- 10-Q
- CIK
- 0001771910
- Primary document
- https://www.sec.gov/Archives/edgar/data/1771910/000177191025000008/adc-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADC Therapeutics SA.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $35.5M | - | - |
| Operating Income | $-72.6M | - | - |
| Net Income | $-95.2M | - | - |
| Eps Basic | -0.86 | - | - |
| Eps Diluted | -0.86 | - | - |
| Cash And Equivalents | $264.6M | - | - |
| Total Assets | $321.6M | - | - |
| Total Liabilities | $520.7M | - | - |
| Shareholders Equity | $-199.2M | - | - |
| Operating Cash Flow | $-80.4M | - | - |
| Capital Expenditures | $264,000 | - | - |